ネプリリシンによる脳アベタの代謝調節
1Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi 351-0198 Japan.
Science (New York, N.Y.)
|May 26, 2001
まとめ
ネプリリシン (neprilysin) は,アミロイドβペプチド (Abeta) を分解する酵素で,アルツハイマー病 (AD) の病理学において重要な役割を果たしています. その欠乏はアベタクリアランスを低下させ,老化に関連したプリリシン減少がADの進行を促す可能性があることを示唆します.
科学分野:
- 神経科学は神経科学である.
- バイオケミストリー バイオケミストリー
- 遺伝学 遺伝学とは
背景:
- アミロイドβペプチド (Abeta) は,アルツハイマー病 (AD) の病原化に関与しています.
- ネプリリシン (Neprilysin) は,脳内のアベタ分解に起因する潜在的な酵素である.
研究 の 目的:
- アベタ代謝におけるプリリシンの役割を調査する.
- アベタ濃度とインビヴォの分布に対するネプリリシン欠乏の影響を決定する.
主な方法:
- アベタ代謝を研究するために,ネプリリシン遺伝子に障害のあるマウスを利用した.
- 外因的なアベータを投与し,内因的なアベータレベルを測定した.
- ネズミの脳における地域的なアベタ分布を分析した.
主要な成果:
- ネプリリシン欠乏症は,外因的なアベタ分解と内因的なアベタ抑制の両方を遺伝子用量依存の方法で低下させた.
- ネプリリシン欠乏したマウスの地域アベータレベルは,ヒポカンプス > 皮質 > タラムス/ストライアタム > 小脳という順番に従った.
- この地域分布は,人間のAD脳におけるアベタ堆積の脆弱性と相関していた.
結論:
- ネプリリシン (Neprilysin) は,アベタ菌の分解における重要な酵素である.
- 潜在的に老化に起因するプリリシン活性低下は,アベタ蓄積とAD発症に寄与する可能性があります.
- ネプリリシンを標的とした治療は,アルツハイマー病の治療戦略となるかもしれません.
関連する概念動画
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:24Phase II Reactions: Acetylation Reactions
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...